Publications by authors named "Simone Luecke"
Article Synopsis
- Neuroendocrine neoplasia grade 3 (NEN G3) is a rare cancer with poor prognosis; this study analyzed real-world data from the German NET Registry to explore treatment and survival outcomes.*
-
- Among the 445 patients examined, 71.5% had advanced stage IV disease, and treatment often involved chemotherapy (43.8%) or surgery (41.6%); the overall median survival was 31 months.*
-
- While survival rates appeared better than some population studies, further research is necessary to determine the most effective treatment strategies for specific patient subgroups.*
